Ispecimen Stock Analysis


USD 1.74  0.09  5.45%   

The current Ispecimen price slip may raise some interest from investors. The stock closed today at a share price of 1.74 on 99,343 in trading volume. The company executives were unable to exploit market volatilities in September. However, diversifying your overall positions with Ispecimen can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.88. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Ispecimen partners.
Please see Risk vs Return Analysis.
The Ispecimen stock analysis report makes it easy to digest most publicly released information about Ispecimen and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Ispecimen Stock analysis module also helps to analyze the Ispecimen price relationship with some important fundamental indicators such as market cap and management efficiency.

Ispecimen Stock Analysis Notes

About 30.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.96. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ispecimen recorded a loss per share of 3.24. The entity had not issued any dividends in recent years. iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts. Ispecimen operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 59 people. To learn more about Ispecimen call the company at 781 301 6700 or check out

Ispecimen Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Ispecimen's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Ispecimen or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Ispecimen generated a negative expected return over the last 90 days
Ispecimen has high historical volatility and very poor performance
Ispecimen may become a speculative penny stock
Ispecimen has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 10.69 M. Net Loss for the year was (7.38 M) with profit before overhead, payroll, taxes, and interest of 5.89 M.
Ispecimen currently holds about 26.1 M in cash with (11.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 30.0% of the company shares are held by company insiders
Latest headline from Benzinga Pinterest Rumors - How The Stock Reacts PINS PLNT CCL AGRI ISPC Podcast - Benzinga

Ispecimen Upcoming and Recent Events

Earnings reports are used by Ispecimen to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Ispecimen previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report3rd of February 2022
Next Fiscal Quarter End31st of December 2021

Ispecimen SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Ispecimen prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Ispecimen investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Ispecimen specific information freely available to individual and institutional investors to make a timely investment decision.
4th of August 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
21st of June 2022
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
26th of May 2022
Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
10th of May 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
29th of April 2022
Financial Statements and Exhibits. Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. Entry into a Material Definitive Agreement
7th of March 2022
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
17th of February 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
14th of February 2022
Unclassified Corporate Event

Ispecimen Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Ispecimen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ispecimen backward and forwards among themselves. Ispecimen's institutional investor refers to the entity that pools money to purchase Ispecimen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Bleichroeder LpCommon Shares65.8 K144 K
Grimes Company IncCommon Shares62 K135 K
Vanguard Group IncCommon Shares61.5 K134 K
Blackrock IncCommon Shares56.7 K124 K
Teton Advisors IncCommon Shares40 K87 K
Geode Capital Management LlcCommon Shares23.3 K50 K
Schonfeld Strategic Advisors LlcCommon Shares19.8 K44 K
Note, although Ispecimen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ispecimen Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 14.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ispecimen's market, we take the total number of its shares issued and multiply it by Ispecimen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Ispecimen Profitablity

Ispecimen's profitability indicators refer to fundamental financial ratios that showcase Ispecimen's ability to generate income relative to its revenue or operating costs. If, let's say, Ispecimen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Ispecimen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Ispecimen's profitability requires more research than a typical breakdown of Ispecimen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (69.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (68.67) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.69.

Management Efficiency

The entity has return on total asset (ROA) of (23.46) % which means that it has lost $23.46 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (193.73) %, meaning that it created substantial loss on money invested by shareholders. Ispecimen management efficiency ratios could be used to measure how well ispecimen manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 4th of October, Ispecimen retains the market risk adjusted performance of (0.05), and Risk Adjusted Performance of (0.013108). Ispecimen technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Ispecimen, which can be compared to its competitors. Please check out Ispecimen treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Ispecimen is priced fairly, providing market reflects its last-minute price of 1.74 per share. Please also validate Ispecimen total risk alpha, which is currently at 0.2551 to confirm the company can sustain itself at a future point.

Ispecimen Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Kaufman Adaptive Moving Average allows the user to define Ispecimen range across which they want the smoothing.

Ispecimen Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ispecimen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ispecimen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ispecimen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Ispecimen Predictive Daily Indicators

Ispecimen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ispecimen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Ispecimen Forecast Models

Ispecimen time-series forecasting models is one of many Ispecimen's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ispecimen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Ispecimen Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ispecimen prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ispecimen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Ispecimen. By using and applying Ispecimen Stock analysis, traders can create a robust methodology for identifying Ispecimen entry and exit points for their positions.
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts. Ispecimen operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.

Current Ispecimen Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ispecimen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ispecimen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
20.0Strong Buy1Odds
Ispecimen current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Ispecimen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Ispecimen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Ispecimen, talking to its executives and customers, or listening to Ispecimen conference calls.
Ispecimen Analyst Advice Details

Ispecimen Stock Analysis Indicators

Ispecimen stock analysis indicators help investors evaluate how Ispecimen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ispecimen shares will generate the highest return on investment. By understating and applying Ispecimen stock analysis, traders can identify Ispecimen position entry and exit signals to maximize returns.
Quick Ratio14.59
Fifty Two Week Low1.5100
Revenue Growth-15.00%
Shares Short Prior Month47.72k
Average Daily Volume Last 10 Day1.87M
Average Daily Volume In Three Month400.87k
Shares Percent Shares Out0.53%
Gross Margins55.18%
Short Percent Of Float0.76%
Forward Price Earnings-1.51
Float Shares6.08M
Fifty Two Week High28.9800
Enterprise Value To Ebitda0.23
Fifty Day Average2.2030
Two Hundred Day Average3.9313
Enterprise Value To Revenue-0.16
Please see Risk vs Return Analysis. You can also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for analysis

When running Ispecimen price analysis, check to measure Ispecimen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ispecimen is operating at the current time. Most of Ispecimen's value examination focuses on studying past and present price action to predict the probability of Ispecimen's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Ispecimen's price. Additionally, you may evaluate how the addition of Ispecimen to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Global Correlations
Find global opportunities by holding instruments from different markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Is Ispecimen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ispecimen. If investors know Ispecimen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ispecimen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Ispecimen is measured differently than its book value, which is the value of Ispecimen that is recorded on the company's balance sheet. Investors also form their own opinion of Ispecimen's value that differs from its market value or its book value, called intrinsic value, which is Ispecimen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ispecimen's market value can be influenced by many factors that don't directly affect Ispecimen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ispecimen's value and its price as these two are different measures arrived at by different means. Investors typically determine Ispecimen value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ispecimen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.